DCIS Precision
  • Consortium
  • General Public
  • Scientific Community
  • Home
  • News
  • Contact
  • Clinical Trials
  • |
  • NL
Select Page
5th World Congress on Controversies in Breast Cancer (CoBrCa 2019, San Francisco)

5th World Congress on Controversies in Breast Cancer (CoBrCa 2019, San Francisco)

by dcis-toegang | Oct 10, 2019 | Home News Item #1, News

PRECISION patient advocates Donna Pinto and Deborah Collyar attended the 5th World Congress on Controversies in Breast Cancer, CoBrCa 2019 in San Francisco from 4th-6th Sep which was co-organized by Prof. Alastair Thompson. Donna chaired debate sessions –...
2nd PRECISION Annual Meeting 13-14 June 2019

2nd PRECISION Annual Meeting 13-14 June 2019

by dcis-toegang | Sep 18, 2019 | Home News Item #1, News, Uncategorized

The whole team gathered for the 2nd Annual PRECISION meeting at The Netherlands Cancer Institute (NKI) in Amsterdam from 11th -12th June 2019. The two day program consisted of talks and poster session by junior researchers, patient advocates and work package leaders...
Feiten en Vragen LORD studie

Feiten en Vragen LORD studie

by dcis-toegang | Sep 18, 2019 | Home News Item #1, Home News Item #2, News, Uncategorized

The Dutch Patient Advocates: Marja van Oirsouw and Ellen Verschuur put together a flyer with information about DCIS and the LORD clinical trial. https://www.dcisprecision.org/wp-content/uploads/2019/09/Feiten-en-vragen-LORD-studie-aangepast.pdf *This information is...
PRECISION publishes it’s first newsletter

PRECISION publishes it’s first newsletter

by dcis-toegang | Aug 7, 2019 | Home News Item #1, News

Read the newsletter by clicking on the link below https://www.dcisprecision.org/wp-content/uploads/2019/08/Final-Newsletter_11th-June-2019.pdf  
PRECISION publishes review article – Ductal carcinoma in situ: to treat or not to treat, that is the question

PRECISION publishes review article – Ductal carcinoma in situ: to treat or not to treat, that is the question

by dcis-toegang | Jul 16, 2019 | Home News Item #2, News, Uncategorized

On 9th July, PRECISION published its latest review article in the British Journal of Cancer. Here, the authors present a global perspective of what it means to be diagnosed with DCIS – its medical, social and emotional impact on lives of women with DCIS. The...
« Older Entries

More News

  • 5th World Congress on Controversies in Breast Cancer (CoBrCa 2019, San Francisco)
  • 2nd PRECISION Annual Meeting 13-14 June 2019
  • Feiten en Vragen LORD studie
  • PRECISION publishes it’s first newsletter
  • PRECISION publishes review article – Ductal carcinoma in situ: to treat or not to treat, that is the question
  • Becoming Professor…
  • ‘Over-diagnosis and over-treatment of breast cancer is a travesty in women’s healthcare’
  • PRECISION @ Association of Breast Surgery Conference 2019 – Future Management of DCIS
  • DCIS Dilemmas – clinician and patient advocate interactive session 13th June, NKI, Amsterdam
  • PRECISION@ESMO Breast Cancer Annual Congress 2019
  • A new study reveals – 6 prognostic factors which may predict invasive breast cancer recurrence after DCIS diagnosis
  • PRECISION Annual Review Meeting 23-25 January 2019
  • San Antonio Breast Cancer Symposium (SABCS) 2018
  • PRECISION annual meeting 25 January 2018
  • Preventing unnecessary breast cancer treatment
©2019 DCISprecision.org | Design by Mediaschip | FAQ | Cookie Policy